Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Methods for Evaluating a Disease Condition


Summary

This technology is aimed at developing a technology for detecting and monitoring conditions characterized by increased cell death, such as cancer and trauma, by the detection of nucleic acid markers. This technology has the ability to be generalized into a platform technology.


Supplementary Information

Inventor: Yuen Shan Lisa Chan | Wai Kwun Rossa Chiu | Yuk Lan Lam | Yuk Ming Dennis Lo | Kai On Ng | Timothy Hudson Rainer | Bo Yin Tsui
Priority Number: CN100529100C
IPC Current: C12Q000168 | G01N003348 | C12N001509 | G01N003350
Assignee Applicant: The Chinese University of Hong Kong
Title: Methods for evaluating a disease condition by nucleic acid detection and fractionation | Nucleic acid in the preparation of a diagnostic evaluation disease state of a patient
Usefulness: Methods for evaluating a disease condition by nucleic acid detection and fractionation | Nucleic acid in the preparation of a diagnostic evaluation disease state of a patient
Summary: The method is useful in evaluating a disease condition in a patient suspected of suffering or known to suffer from the disease condition (claimed).
Novelty: Evaluating a disease condition in a patient suspected of suffering or known to suffer from the disease condition by nucleic acid detection and fractionation


Industry

Disease Diagnostic/Treatment


Sub Group

Other Disease


Application No.

02/MED/103


Others

Inventor(s): Professor Dennis Y M Lo, Department of Chemical Pathology

Patent Status:  US Patent Pending  Australian Patent Pending  Japanese Patent Pending  European Patent Pending  Chinese Patent Pending  Hong Kong Patent Pending


Country/Region

Hong Kong

For more information, please click Here
Business of IP Asia Forum
Desktop View